Robert H. Scannevin

10.5k citations

59 papers · 5.6k indexed · 1 hit paper · h-index 30

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 1%
Neurology top 0.5%
Pathology and Forensic Medicine top 2%
Immunology top 5%

Co-authors: Richard L. Huganir Kenneth J. Rhodes James S. Trimmer Jun Xia Xiaoqun Zhang Hee Jung Chung Matvey Lukashev Sarah Ryan
Topics: Genomics, phytochemicals, and oxidative stress (12 papers)Neuroinflammation and Neurodegeneration Mechanisms (9 papers)Multiple Sclerosis Research Studies (8 papers)
Cited by: Neurology Cellular and Molecular Neuroscience Biological Psychiatry
Journals: Cell Proceedings of the National Academy of Sciences Nature Communications
Partner nations: United States Germany Italy

In The Last Decade

Robert H. Scannevin

58 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

2011 892 citations Sarah Ryan, Pradeep Bista et al. profile →

Peers

Countries citing papers authored by Robert H. Scannevin

Since Specialization

Citations

This map shows the geographic impact of Robert H. Scannevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Scannevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Scannevin more than expected).

Fields of papers citing papers by Robert H. Scannevin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Scannevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Scannevin. The network helps show where Robert H. Scannevin may publish in the future.

Co-authorship network of co-authors of Robert H. Scannevin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Scannevin. A scholar is included among the top collaborators of Robert H. Scannevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Scannevin. Robert H. Scannevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fatty acids as potential biomarkers of stearoyl-CoA desaturase inhibition: Variation in healthy subjects and Parkinson's disease patients 2025 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),(unknown),Robert H. Scannevin,(unknown),Emilie M.J. van Brummelen,Brigitte Robertson,Philip H. C. Kremer,Geert Jan Groeneveld	1
2	Patient-derived three-dimensional cortical neurospheres to model Parkinson’s disease 2022 ·PLoS ONE ·(unknown),(unknown),Christopher J. Burke,Xin Jiang,Ping Xu,Kenneth J. Rhodes,Vikram Khurana,Robert H. Scannevin,Chee Yeun Chung	6
3	A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity 2022 ·Neurotherapeutics ·Silke Nuber,Chee Yeun Chung,Daniel F. Tardiff,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Xin Jiang,Ping Xu,Vikram Khurana,Ulf Dettmer,Saranna Fanning,Kenneth J. Rhodes,Dennis J. Selkoe,Robert H. Scannevin	11
4	Automated algorithm development to assess survival of human neurons using longitudinal single-cell tracking: Application to synucleinopathy 2022 ·SLAS TECHNOLOGY ·(unknown),(unknown),J. Daniel Nelson,(unknown),(unknown),(unknown),Takayuki Uozumi,Yasujiro Kiyota,(unknown),Kenneth J. Rhodes,Robert H. Scannevin,Heather Sadlish,Chee Yeun Chung	0
5	Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease 2022 ·Molecular Neurobiology ·Daniel F. Tardiff,Matthew C. Lucas,Iwona Wrona,(unknown),Chee Yeun Chung,Bertrand Le Bourdonnec,Kenneth J. Rhodes,Robert H. Scannevin	18
6	Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity 2018 ·Cell Reports ·Benjamin Vincent,Daniel F. Tardiff,Jeff S. Piotrowski,Rebecca Aron,Matthew C. Lucas,Chee Yeun Chung,Helene Bacherman,(unknown),(unknown),(unknown),(unknown),Heather Sadlish,(unknown),(unknown),Vikram Khurana,Bertrand Le Bourdonnec,Robert H. Scannevin,Kenneth J. Rhodes	102
7	Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease 2016 ·Antioxidants and Redox Signaling ·Isabel Lastres‐Becker,Ángel J. García‐Yagüe,Robert H. Scannevin,Marı́a José Casarejos,Sebastian Kügler,Alberto Rábano,Antonio Cuadrado	227
8	Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms 2016 ·Antioxidants and Redox Signaling ·Melanie S. Brennan,Hiral Patel,Norm Allaire,(unknown),Patrick Cullen,Sarah Ryan,Matvey Lukashev,Pradeep Bista,Ron Huang,Kenneth J. Rhodes,Robert H. Scannevin	48
9	Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2 2015 ·Nature Communications ·Karen Bell,Bashayer Al‐Mubarak,(unknown),Sean McKay,(unknown),Philip Hasel,Nóra M. Márkus,Paul Baxter,Ruth F. Deighton,Andrea Serio,Bilada Bilican,Sudhir Chowdhry,Paul J. Meakin,Michael L.J. Ashford,David J. A. Wyllie,Robert H. Scannevin,Siddharthan Chandran,John D. Hayes,Giles E. Hardingham	155
10	Dimethyl Fumarate Alters Microglia Phenotype and Protects Neurons Against Proinflammatory Toxic Microenvironments (P1.163) 2015 ·Neurology ·Haiyan Peng,Maria Auxiliadora Costa Matos,Brian T. Wipke,H. Moore Arnold,Robert H. Scannevin	2
11	Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 2015 ·Acta Neuropathologica ·Benedetta Parodi,Silvia Rossi,Sara Morando,Christian Cordano,Alberto Bragoni,Caterina Motta,Cesare Usai,Brian T. Wipke,Robert H. Scannevin,Gianluigi Mancardi,Diego Centonze,Nicole Kerlero de Rosbo,Antonio Uccelli	156
12	Tolerability and Pharmacokinetics of Delayed-Release Dimethyl Fumarate Administered With and Without Aspirin in Healthy Volunteers 2013 ·Clinical Therapeutics ·Sarah Sheikh,Ivan Nestorov,(unknown),John O’Gorman,Ron Huang,Ginger L. Milne,Robert H. Scannevin,Mark Novas,Katherine Dawson	48
13	Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Brian C. Shook,(unknown),J. Kent Barbay,Aihua Wang,Kristi Leonard,(unknown),Mark T. Powell,Stefanie Rassnick,Robert H. Scannevin,Karen Carroll,Nathaniel Wallace,Jeffrey J. Crooke,(unknown),(unknown),Lori Westover,Kenneth J. Rhodes,Paul Jackson	18
14	Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Robert H. Scannevin,Sowmya Chollate,Mi-Young Jung,(unknown),Hiral Patel,Pradeep Bista,Weike Zeng,Sarah Ryan,Masayuki Yamamoto,Matvey Lukashev,Kenneth J. Rhodes	380
15	Arc/Arg3.1 Regulates an Endosomal Pathway Essential for Activity-Dependent β-Amyloid Generation 2011 ·Cell ·Jing Wu,Ronald S. Petralia,(unknown),Hiral Patel,(unknown),Lenora J. Volk,Shoaib Chowdhury,Jason D. Shepherd,Marlin H. Dehoff,Yue‐Ming Li,Dietmar Kuhl,Richard L. Huganir,Donald L. Price,Robert H. Scannevin,Juan C. Troncoso,Philip C. Wong,Paul Worley	168
16	Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy 2011 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence J. Wilson,Bingbing Wang,(unknown),Robert H. Scannevin,Sharon L. Burke,Prabha Karnachi,Kenneth J. Rhodes,William V. Murray	7
17	Stereochemistry–activity relationship of orally active tetralin S1P agonist prodrugs 2010 ·Bioorganic & Medicinal Chemistry Letters ·Bin Ma,Kevin M. Guckian,Edward Yin-Shiang Lin,Wen‐Cherng Lee,Daniel J. Scott,G. Kumaravel,Timothy L. Macdonald,Kevin R. Lynch,Cheryl Black,Sowmya Chollate,Kyungmin Hahm,(unknown),Ping Jin,Yi Luo,Ellen Rohde,Anthony Rossomando,Robert H. Scannevin,Joy Wang,Chunhua Yang	9
18	β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 1. Design, synthesis, and lead identification 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Robert H. Scannevin,Bingbing Wang,Sharon L. Burke,Lawrence J. Wilson,Prabha Karnachi,Kenneth J. Rhodes,Bharat Lagu,William V. Murray	24
19	Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs) 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yuemei Zhang,(unknown),(unknown),Robert H. Scannevin,Sharon L. Burke,Kenneth J. Rhodes,Paul Jackson	36
20	Postsynaptic organisation and regulation of excitatory synapses 2000 ·Nature reviews. Neuroscience ·Robert H. Scannevin,Richard L. Huganir	369

About Robert H. Scannevin

Robert H. Scannevin is a scholar working on Neurology, Physiology and Biological Psychiatry, having authored 59 papers that have together received 5.6k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Multiple Sclerosis Research Studies (8 papers). The work is most often cited by research in Neurology (877 citations), Cellular and Molecular Neuroscience (1.6k citations) and Biological Psychiatry (205 citations). Robert H. Scannevin has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Richard L. Huganir, Kenneth J. Rhodes, James S. Trimmer, Jun Xia, Xiaoqun Zhang, Hee Jung Chung, Matvey Lukashev, Sarah Ryan, Pradeep Bista and Sowmya Chollate. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact